These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 18006828)

  • 1. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T; Budhu A; Forgues M; Wang XW
    Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
    Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW
    Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.
    Yamashita T; Ji J; Budhu A; Forgues M; Yang W; Wang HY; Jia H; Ye Q; Qin LX; Wauthier E; Reid LM; Minato H; Honda M; Kaneko S; Tang ZY; Wang XW
    Gastroenterology; 2009 Mar; 136(3):1012-24. PubMed ID: 19150350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the relationship among microRNA-181, epithelial cell-adhesion molecule (EpCAM) and beta-catenin in hepatic cancer stem cells.
    Li JP; Zheng JY; Du JJ; Zhang R; Yang AG
    Hepatology; 2009 Dec; 50(6):2047-8; author reply 448. PubMed ID: 19937678
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide.
    Fako V; Yu Z; Henrich CJ; Ransom T; Budhu AS; Wang XW
    Int J Biol Sci; 2016; 12(7):768-75. PubMed ID: 27313491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas.
    Mebarki S; Désert R; Sulpice L; Sicard M; Desille M; Canal F; Dubois-Pot Schneider H; Bergeat D; Turlin B; Bellaud P; Lavergne E; Le Guével R; Corlu A; Perret C; Coulouarn C; Clément B; Musso O
    Oncotarget; 2016 Jun; 7(26):39026-39043. PubMed ID: 27191501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets.
    Kavak E; Najafov A; Ozturk N; Seker T; Cavusoglu K; Aslan T; Duru AD; Saygili T; Hoxhaj G; Hiz MC; Unal DO; Birgül-Iyison N; Ozturk M; Koman A
    Cell Signal; 2010 Oct; 22(10):1523-35. PubMed ID: 20538055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells.
    Yang W; Yan HX; Chen L; Liu Q; He YQ; Yu LX; Zhang SH; Huang DD; Tang L; Kong XN; Chen C; Liu SQ; Wu MC; Wang HY
    Cancer Res; 2008 Jun; 68(11):4287-95. PubMed ID: 18519688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
    Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
    Yamashita T; Honda M; Nio K; Nakamoto Y; Yamashita T; Takamura H; Tani T; Zen Y; Kaneko S
    Cancer Res; 2010 Jun; 70(11):4687-97. PubMed ID: 20484035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.
    Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM
    Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.
    Chan DW; Chan CY; Yam JW; Ching YP; Ng IO
    Gastroenterology; 2006 Oct; 131(4):1218-27. PubMed ID: 17030191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
    Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI
    Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells.
    Henrich CJ; Budhu A; Yu Z; Evans JR; Goncharova EI; Ransom TT; Wang XW; McMahon JB
    Chem Biol Drug Des; 2013 Aug; 82(2):131-9. PubMed ID: 23879724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. βII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin.
    Zhi X; Lin L; Yang S; Bhuvaneshwar K; Wang H; Gusev Y; Lee MH; Kallakury B; Shivapurkar N; Cahn K; Tian X; Marshall JL; Byers SW; He AR
    Hepatology; 2015 Feb; 61(2):598-612. PubMed ID: 25307947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of EpCAM overexpression on human breast cancer cell lines.
    Gostner JM; Fong D; Wrulich OA; Lehne F; Zitt M; Hermann M; Krobitsch S; Martowicz A; Gastl G; Spizzo G
    BMC Cancer; 2011 Jan; 11():45. PubMed ID: 21281469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma.
    Liu G; Jiang S; Wang C; Jiang W; Liu Z; Liu C; Saiyin H; Yang X; Shen S; Jiang D; Zhou P; Han D; Hu X; Yi Q; Yu L
    Hepatology; 2012 Jun; 55(6):1830-9. PubMed ID: 22213192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.